凋亡系列产品

Caspase 3 Antibody (NB500-210)
Application: Western Blot
Sample Tested: Human Hepatoblastoma
Species: Human

Caspase 9 Antibody (NB500-209)
Application: Western Blot
Sample Tested: COLO-205 Cell Line
Species: Human

[Bcl2 Antibody NBP1-72213] Am J Clin Oncol. 2008 Dec;31(6):585-8. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer. Camlica H, Duranyildiz D, Tas F, Yasasever V. Department of Preventive Oncology, Biostatistics and Epidemiology, Institute of Oncology, University of Istanbul, Istanbul, Turkey.
[Caspase 3 Antibody NB500-210] Dash R, Azab B, Quinn BA, et al. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells tomda-7/IL-24-mediated toxicity. Proc Natl Acad Sci U S A. 2011 May 24;108(21):8785-90.[PMID 21555592]
[Caspase 3 Antibody NB500-210] Rothberg BEG, Bracken MB, Rimm DL. Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review Meta-analysis. J Natl Cancer Inst 2009;101(7):452-474 [pubmed: 19318635]
[Caspase 3 Antibody NB500-210] Kulkarni AA, Kingsbury SR, Tudzarova S, et al. Cdc7 Kinase Is a Predictor of Survival a Novel Therapeutic Target in Epithelial Ovarian Carcinoma. Clin Cancer Res 2009;15(7):2417-2425 [pubmed: 19318489]
[Caspase 7 Antibody NB110-55664] Nikiforov MA, Riblett M, Tang W-H, et al. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. PNAS. 2007 December 4, 2007;104(49):19488-93.
[Survivin Antibody NB500-201] El Ghamrasni S, Pamidi A, Halaby MJ, et al. Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer. PLoS Genet.PLoS Genet. 2011 May;7(5):e1001385 [PMID 21625617]
欢迎使用Novus Explorer搜索与凋亡相关的产品与文献，链接为：http://www.novusbio.com/explorer。